Product Brochure

Advantose™ 100 - Direct Compression Tableting Excipient

Format: Webpage | Document type: Product Brochure | Promoted Content

This content is provided by SPI Pharma, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Advantose™ 100 - Direct Compression Tableting Excipient

High speed tablet and encapsulating equipment requires materials that flow easily, compact robustly, and that minimize weight variation to ensure content uniformity. Added to USP/NF in 2004, Advantose™ 100​ was designed specifically with high speed pharmaceutical manufacturing in mind.

Advantose™ 100​, with its consistent uniform spray dried particle is quickly being recognized by pharmaceutical formulators world wide as having exceptional flow and compaction properties. In addition, because Advantose™ 100​ is highly soluble, it has been shown to reduce disintegration times without additional disintegrants when substituted for MCC, Lactose, and DCP. Produced from natural grain, Advantose™ 100​ is BSE and TSE free.

Unlike most other tablet binders, Advantose™ 100​ has an enhancing synergistic effect when used in combination with other excipients such as MCC and Mannitol, to improve tablet or capsule slug performance compared to those excipients alone. Because of its exceptional flow properties, it often eliminates the need for the additional flow aides.

To learn more go to www.spipharma.com​ to review the Advantose™ 100 Technical Bulletin or request copies of published research reports on the advantages of Advantose™ 100, or contact SPI Pharma or any of our worldwide distributors.

Supplier info centre